EDMONTON, Alberta, Jan. 25 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has received orders for 1.5 million VScan HIV test kits as a result of its participation in the Dubai Medical Conference. These orders will generate revenue of approximately $3.5 million US over the next 15 months.
The orders totaling 1.5 million VScan HIV test kits are from two Middle East countries. Medical Services is to deliver the test kits in 12 equal orders over a period of one year starting May 1, 2006. Payment for the test kits will be by Irrevocable Letter of Credit from a Western Bank. In addition to the above, our distributor is negotiating with several other countries and expects to receive additional orders that will be in excess of 1.0 million HIV test kits. The company feels that this will be an excellent market for the VScan HIV test kit as a result of its accuracy and specialty use in remote areas using whole blood so that the testing can be completed without medical facilities and trained medical personnel. There has also been significant interest in our VScan TB test kits and Hepatitis C test kits. We believe that these test kits will generate a secondary market.
About VScan
The VScan rapid test kit is a single use, easy to use test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Malaria, Syphilis and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to, new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or media contact Bill Whitehead,+1-416-822-5883, both of Medical Services International Inc.
